Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG,
Lakkireddy D, Olshansky B. Arrhythmia-Induced Cardiomyopathies:
Mechanisms, Recognition, and Management. J Am Coll Cardiol.
2015;66(15):1714-28
Kim DY, Kim SH, Ryu KH. Tachycardia induced cardiomyopathy.
Korean
Circ J. 2019;49(9):808-817
Nakamura R, Egashira K, Machida Y, Hayashidani S, Takeya M, Utsumi H,
Tsutsui H, Takeshita A. Probucol attenuates left ventricular
dysfunction and remodeling in tachycardia-induced heart failure: roles
of oxidative stress and inflammation. Circulation 2002;106:362–7.
Nerheim P, Birger-Botkin S, Piracha L, Olshansky B. Heart failure and
sudden death in patients with tachycardia-induced cardiomyopathy and
recurrent tachycardia. Circulation 2004;110:247–52.
Wijesurendra RS, Liu A, Eichhorn
C, Ariga R, Levelt E, Clarke WT, Rodgers CT, Karamitsos TD, Bashir Y,
Ginks M, Rajappan K, Betts T, Ferreira VM, Neubauer S, Casadei B. Lone
atrial fibrillation is associated with impaired left ventricular
energetics that persists despite successful catheter ablation.
Circulation 2016;134:1068–81.
Pabel S. Functional and molecular mechanisms in tachycardia-mediated
cardiomyopathy. Deutsch Med Wschr 2019;144(15):suppl., page 46